Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9Z2F2

Entry ID Method Resolution Chain Position Source
AF-Q9Z2F2-F1 Predicted AlphaFoldDB

42 variants for Q9Z2F2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388789562 52 E>K No EVA
rs3396196387 73 G>V No EVA
rs32140123 75 T>M No EVA
rs3388784292 81 D>V No EVA
rs32141034 95 E>K No EVA
rs13463536 102 E>D No EVA
rs3388774781 120 A>D No EVA
rs32141035 124 I>F No EVA
rs3388772133 128 H>Q No EVA
rs3395682302 130 E>G No EVA
rs29822904 134 A>P No EVA
rs29822904 134 A>T No EVA
rs3388789618 177 E>D No EVA
rs32141038 185 Y>H No EVA
rs3388772104 206 V>I No EVA
rs3388789605 221 Q>L No EVA
rs3388789572 241 L>M No EVA
rs3388753746 256 S>N No EVA
rs3388753725 257 F>I No EVA
rs3388777495 273 Y>F No EVA
rs32142001 274 R>H No EVA
rs3388753724 282 K>N No EVA
rs3388786221 288 N>Y No EVA
rs246493875 320 K>N No EVA
rs3388776392 330 A>D No EVA
rs3388783931 335 Q>* No EVA
rs32142969 339 T>R No EVA
rs229463169 345 E>K No EVA
rs3396091067 351 R>G No EVA
rs245249232 351 R>P No EVA
rs265278756 352 A>S No EVA
rs3396029785 353 R>K No EVA
rs255682007 431 F>I No EVA
rs3388776328 433 P>H No EVA
rs32145416 450 T>A No EVA
rs3388764463 456 T>I No EVA
rs3388783375 469 G>D No EVA
rs218463708 472 A>V No EVA
rs252740003 476 V>I No EVA
rs3388774829 479 L>* No EVA
rs32145417 491 K>E No EVA
rs13463538 508 D>H No EVA

No associated diseases with Q9Z2F2

5 regional properties for Q9Z2F2

Type Name Position InterPro Accession
domain Ubiquitin-like domain 435 - 506 IPR000626
domain 2-5OAS/ClassI-CCAase, nucleotidyltransferase domain 29 - 214 IPR006116
conserved_site 2-5-oligoadenylate synthetase, C-terminal conserved site 303 - 313 IPR006117
domain 2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal 170 - 351 IPR018952
conserved_site 2-5-oligoadenylate synthetase, N-terminal conserved site 68 - 87 IPR043518

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

4 GO annotations of molecular function

Name Definition
2'-5'-oligoadenylate synthetase activity Catalysis of the reaction: ATP = pppA(2'p5'A)n oligomers. This reaction requires the binding of double-stranded RNA.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
double-stranded RNA binding Binding to double-stranded RNA.
metal ion binding Binding to a metal ion.

7 GO annotations of biological process

Name Definition
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
interleukin-27-mediated signaling pathway The series of molecular signals initiated by interleukin-27 binding to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
negative regulation of viral genome replication Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication.
purine nucleotide biosynthetic process The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
regulation of ribonuclease activity Any process that modulates the rate, frequency, or extent of ribonuclease activity, catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.
response to virus Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q2T9Q2 UBL4B Ubiquitin-like protein 4B Bos taurus (Bovine) PR
P11441 UBL4A Ubiquitin-like protein 4A Homo sapiens (Human) PR
Q9CQ84 Ubl4b Ubiquitin-like protein 4B Mus musculus (Mouse) PR
P11928 Oas1a 2'-5'-oligoadenylate synthase 1A Mus musculus (Mouse) PR
Q5MYT9 Oasl2 2'-5'-oligoadenylate synthase-like protein 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MDPFPDLYAT PGDSLDHFLE HSLQPQRDWK EEGQDAWERI ERFFREQCFR DELLLDQEVR
70 80 90 100 110 120
VIKVVKGGSS GKGTTLNHRS DQDMILFLSC FSSFEEQARN REVVISFIKK RLIHCSRSLA
130 140 150 160 170 180
YNIIVLTHRE GKRAPRSLTL KVQSRKTDDI IWMDILPAYD ALGPISRDSK PAPAIYETLI
190 200 210 220 230 240
RSKGYPGDFS PSFTELQRHF VKTRPVKLKN LLRLVKFWYL QCLRRKYGRG AVLPSKYALE
250 260 270 280 290 300
LLTIYAWEMG TESSDSFNLD EGFVAVMELL VNYRDICIYW TKYYNFQNEV VRNFLKKQLK
310 320 330 340 350 360
GDRPIILDPA DPTNNLGRRK GWEQVAAEAA FCLLQVCCTT VGPSERWNVQ RARDVQVRVK
370 380 390 400 410 420
QTGTVDWTLW TNPYSPIRKM KAEIRREKNF GGELRISFQE PGGERQLLSS RKTLADYGIF
430 440 450 460 470 480
SKVNIQVLET FPPEILVFVK YPGGQSKPFT IDPDDTILDL KEKIEDAGGP CAEDQVLLLD
490 500
DEELEDDESL KELEIKDCDT IILIRVID